In situ detection of cyclic AMP-phosphodiesterase activity in the heart of Lewis and Sprague-Dawley rats: the effect of restraint stress or amphetamine application.
Cyclic AMP plays an important role in heart functions under normal as well as pathological conditions. Since phosphodiesterase (PDE), responsible for the hydrolysis of cAMP, is equally important as synthesizing adenylyl cyclase, we decided to determine its activity by cytochemical procedure after exposure of rats to restraint stress or an acute dose of amphetamine. Sprague-Dawley (S-D) and Lewis (LE) rats, the latter known to have a deficient hypothalamo-pituitary-adrenal axis activity, were used in order to disclose the possible significance of rat strain on PDE activity. Animals were divided into 3 groups: controls, rats treated with an acute dose of amphetamine (8 mg/kg, i.p., for 60 min) and rats under restraint stress for 60 min. Control hearts of both strains revealed PDE activity on sarcolemma of cardiomyocytes and plasmalemma of endothelial cells of microvessels. In LE rats we observed an additional enzyme reaction in junctional sarcoplasmic reticulum. In addition, cardiomyocytes of LE rats revealed a higher PDE activity when compared to S-D rats. Restraint stress decreased PDE activity in cardiomyocytes of LE rats while amphetamine markedly inhibited enzyme activity in cardiomyocytes of S-D rats. Endothelial PDE was more resistant to stress. Our results indicate differences in PDE localization and variations in sensitivity of myocardial cAMP-PDE of LE and S-D rat strains to restraint stress and amphetamine application.
Okruhlicová
L
L
Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic. usrdokru@savba.sk
Klenerová
V
V
Hynie
S
S
Sída
P
P
D000662:Amphetamines / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D002196:Capillaries / Q000648:ultrastructure; D002462:Cell Membrane / Q000187:drug effects / Q000201:enzymology / Q000473:pathology / Q000648:ultrastructure; D000242:Cyclic AMP / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000201:enzymology / Q000473:pathology / Q000648:ultrastructure; D006352:Heart Ventricles / Q000648:ultrastructure; D006651:Histocytochemistry; D007103:Immobilization; D007274:Injections, Intraperitoneal; D008297:Male; D009206:Myocardium / Q000201:enzymology* / Q000648:ultrastructure; D032383:Myocytes, Cardiac / Q000187:drug effects / Q000201:enzymology / Q000473:pathology / Q000648:ultrastructure; D010727:Phosphoric Diester Hydrolases / Q000187:drug effects* / Q000378:metabolism; D051381:Rats; D011917:Rats, Inbred Lew; D017207:Rats, Sprague-Dawley; D012508:Sarcolemma / Q000187:drug effects / Q000201:enzymology / Q000473:pathology / Q000648:ultrastructure; D012519:Sarcoplasmic Reticulum / Q000187:drug effects / Q000201:enzymology / Q000473:pathology / Q000648:ultrastructure; D013045:Species Specificity; D013312:Stress, Physiological; D013997:Time Factors
D000662:Amphetamines; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases